127 related articles for article (PubMed ID: 4716182)
1. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
Hsiao YY; Bardos TJ
J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
[No Abstract] [Full Text] [Related]
2. Alkylating analogues of the tumour inhibitor 5-aziridino-2,4-dinitrobenzamide.
Tisdale MJ
Chem Biol Interact; 1971 Apr; 3(2):95-107. PubMed ID: 5156644
[No Abstract] [Full Text] [Related]
3. Alkylating agents related to 2,2'-biaziridine. 3. The stereoisomeric N,N'-dimethanesulfonyl-2,2'-biaziridines.
Feit PW; Nielsen OT
J Med Chem; 1970 May; 13(3):447-52. PubMed ID: 5460301
[No Abstract] [Full Text] [Related]
4. Alkylating agents related to 2,2'-biaziridine. II. N,N'-dicarbethoxy-2,2'-biaziridine.
Feit PW; Nielsen OT
J Med Chem; 1967 Sep; 10(5):927-32. PubMed ID: 6048504
[No Abstract] [Full Text] [Related]
5. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
Foster AB; Jarman M; Ross WC; Tisdale MJ
J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
[No Abstract] [Full Text] [Related]
6. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
Noell CW; Cheng CC
J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
[No Abstract] [Full Text] [Related]
7. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
[No Abstract] [Full Text] [Related]
8. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
Hsiao YY; Bardos TJ; Wampler GL; Regelson W
J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
Wampler GL; Kuperminc M; Regelson W
Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity correlations of anticancer agents: diaminopyrimidines, N-acyltriamines, bis-(1-aziridinyl)-phosphinyl carbamates, and aromatic nitrogen mustards.
Lien EJ; Tong GL
Cancer Chemother Rep; 1973; 57(3):251-61. PubMed ID: 4796118
[No Abstract] [Full Text] [Related]
11. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS IV. EFFECT OF RING SUBSTITUENTS ON THE ALKYLATING AND HYDROLYTIC PROPERTIES OF BIS-(1-AZIRIDINYL)PHOSPHINYL CARBAMATES.
BARDOS TJ; CHMIELEWICZ ZF; NAVADA CK
J Pharm Sci; 1965 Mar; 54():399-403. PubMed ID: 14302149
[No Abstract] [Full Text] [Related]
12. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
[TBL] [Abstract][Full Text] [Related]
13. [On the cytostatic effect of new synthetic carbamoyl esters "in vivo". 1].
Demetrescu C; Gheorghiu P; Görk E; Chirită C; Mavrodin A; Teitel A
Pharmazie; 1965 Oct; 20(10):634-6. PubMed ID: 5880091
[No Abstract] [Full Text] [Related]
14. Potential bioreductive alkylating agents. 3. Synthesis and antineoplastic activity of acetoxymethyl and corresponding ethyl carbamate derivatives of benzoquinones.
Lin AJ; Shansky CW; Sartorelli AC
J Med Chem; 1974 May; 17(5):558-61. PubMed ID: 4830263
[No Abstract] [Full Text] [Related]
15. Effects of three aziridine alkylating compounds on the gross development of chicken embryos.
Younger RL
Toxicol Appl Pharmacol; 1973 Mar; 24(3):423-33. PubMed ID: 4122266
[No Abstract] [Full Text] [Related]
16. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
[No Abstract] [Full Text] [Related]
17. [Quantitative aspects of the relationship of the antitumor activity and toxicity of diaziridinyl-sym. triazines to their physicochemical properties].
Ivin BA; Filov VA; Kraĭz BO; Belogorodskiĭ VV; Maliugina LL
Vopr Onkol; 1979; 25(7):71-5. PubMed ID: 483685
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
[No Abstract] [Full Text] [Related]
19. Tumour-growth inhibitory nitrophenylaziridines and related compounds: structure-activity relationships. II.
Khan AH; Ross WC
Chem Biol Interact; 1971 Dec; 4(1):11-22. PubMed ID: 5156332
[No Abstract] [Full Text] [Related]
20. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
